BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split
October 30, 2024
LAS VEGAS, Oct. 29, 2024 (GLOBE NEWSWIRE) — via IBN — Due to a website maintenance error, a draft of a letter to BioAdaptives® (OTC: BDPT) shareholders was made available on the BioAdaptives® website. While the timing was unfortunate, it raised awareness of an upcoming event critical for the long-term health of BioAdaptives®. On Jan. 1, 2020, […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray
June 25, 2024
Pressure BioSciences (OTCQB: PBIO), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the largest distributor in the world of freeze-dried Acai (a potent antioxidant) to develop a highly bioavailable, multi-antioxidant oral spray. […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Business and Financial Update Teleconference
June 18, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors and other stakeholders on various business and financial topics. The teleconference , scheduled to take place starting […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Schedules Business, Financial Update
June 13, 2024
Pressure BioSciences (OTCQB: PBIO) is a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries. The company today announced that it will host a teleconference on Wednesday, June 19, 2024, at 4:30 p.m. ET to update investors and other stakeholders on various […]
InvestorNewsBreaks – BioAdaptives, Inc. (BDPT) Appoints Car Rental Industry Veteran to Its Board of Directors
May 30, 2024
BioAdaptives (OTC: BDPT), a leader in the health and wellness sector, is announcing the appointment of Gimhana Dissanayake to its Board of Directors. According to the announcement, Gimhana brings over two decades of comprehensive experience and a proven track record of strategic growth and operational excellence to the company. He currently serves as the vice […]
BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors
May 30, 2024
We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights. LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) — via IBN — BioAdaptives, Inc. (OTC: BDPT), a leader in the health and wellness sector, today announces the appointment of Gimhana Dissanayake to its Board of Directors. Gimhana, who currently […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Plans Expansion to Successful New Premium Collection
April 11, 2024
Pressure BioSciences (OTCQB: PBIO) and its wholly owned subsidiary, Uncle Bud’s, are expanding the Premium Collection of state-of-the-art nanoemulsified products. The line of Premium Collection products combines innovation in performance and quality with a new generation of diverse nanoemulsion products that offer preservative-free, organic, “clean and green,” all-natural wellness solutions. The first product available under […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Reports Initial Offering in Uncle Bud’s New Premium Collection Sees ‘Enthusiastic Customer Response’
April 2, 2024
Pressure BioSciences (OTCQB: PBIO) and its wholly owned subsidiary, Uncle Bud’s, are reporting significant sales of it its revolutionary nanoemulsified CBD product: CBD Body Revive Spray; the spray has 1,200 mg of Nano-CBD. CBD Body Revive Spray is the initial product in Uncle Bud’s Premium Collection, which has been an immediate success. The Premium Collection […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Significant Success with Recent Acquisition
February 26, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is releasing information on the growth of its recent acquisition: Uncle Bud’s Health & Wellness. According […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Consolidate All Operations in New Boston-Based Facility
February 15, 2024
Pressure BioSciences (OTCQB: PBIO), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly enabling, pressure-based instruments and nanoemulsion products and services for the health and wellness, food and beverage, pharmaceutical, and other industries, has achieved a significant milestone in its accelerating growth journey. The company has consolidated its Boston-area […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces New UB Product Line, Plans Investor Teleconference
February 5, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, is hosting a teleconference today. According to the announcement, during the call company officials will discuss […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Upcoming Investor Teleconference to Discuss Key Company Milestones
February 1, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, has scheduled a teleconference. The Feb. 5, 2024, event will focus on PBIO’s current, in-process move […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Closes on Acquisition of Uncle Bud’s in All-Stock Transaction
January 22, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, has closed on the acquisition of natural health and wellness leader Uncle Bud’s (“UB”). The acquisition […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures New Client Launching Around UltraShear(TM) Nanoemulsions Platform
January 18, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced the receipt of an open order agreement. The agreement is for the purchase in 2024 of a minimum of 10,000 bottles (over $300,000) of the company’s […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Tremendous Opportunity Through Strategic Merger, UltraShear
January 16, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, recently entered a definitive agreement to acquire renowned natural health and wellness leader Uncle Bud’s. Today, the company announced the beginning of summer season order filling with one […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Moves to Acquire Uncle Bud’s, Accelerate UltraShear(TM) Technology into Multiple Markets
January 11, 2024
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, has entered a definitive agreement to acquire globally renowned natural health and wellness leader Uncle Bud’s. Upon closing of the transaction, the combined company intends to become a […]
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UltraShear(TM) Platform Featured in Food Technology Article
December 21, 2023
Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced a powerful visionary article in the respected industry trade magazine, Food Technology, published by the Institute of Food Technologists (“IFT”). The world’s largest professional scientific non-profit […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Publication of Report Showing Potential for Proprietary UltraShear(TM) Platform
December 13, 2023
Pressure BioSciences (OTCQB: PBIO), a leading developer and provider of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including food and beverage, health and wellness, nutraceuticals, cosmetics, biotherapeutics and more, is reporting on the publication of a key scientific study. According to the announcement, the study is in […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Veterans Service Team Announce Launch of ‘Valor CBD’
December 1, 2023
Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. The company, together with the Veterans Service Team (“VST”), a self-funded, 501(c)(3) non-profit company dedicated to the support and wellness […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2023 Financial Report, Business Update
November 21, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty-testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmeceuticals, agriculture, and food & beverage industries, is reporting company financial results for the third quarter ended Sept. 30, 2023. The company also released a business update and limited […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2023 Results, Provide Business Update
November 20, 2023
Pressure BioSciences (OTCQB: PBIO) today announced that it will host a teleconference to discuss its third quarter 2023 financial results and to provide a business update. The teleconference, set to take place at 4:30 p.m. ET on Tuesday, Nov. 21, 2023, will include a company presentation followed by a question and answer period. To attend […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Nano CB ‘Vastly Outperforms Current Technologies,’ According to Independent Study
November 9, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, agrochemical, and other industries has received “powerful scientific validation” through an independent peer-reviewed scientific study. According to the announcement, globally renowned cannabis/natural products researcher […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) BaroFold Technology Platform Featured at International Bioprocess Conference
November 2, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries, is collaborating with scientists from Lonza Biologics. According to the announcement, the two companies are working to present convincing […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Exclusive Distribution Agreement with Premier India Distributor in Life Sciences Space
October 18, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has partnered with Bioscreen Instruments PVT LTD through an exclusive instrument and consumables distribution agreement for India. Bioscreen is […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures First Canadian Patent for Revolutionary UltraShear(TM) Platform
October 10, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global pharmaceuticals, nutraceuticals, cosmeceuticals, food/beverage and other industries. The company today announced the award of the first Canadian patent for its revolutionary UltraShear(TM) Technology (“UltraShear(TM)” or “USTTM”) […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures 10X Increase in Existing VST Purchase Order
September 22, 2023
Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. PBIO, together with the Veterans Service Team (“VST”) (www.vst.org), a self-funded, 501(c)3 non-profit company dedicated to the support and wellness […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Begins Fulfillment of UltraShear Nano-CBD Orders
September 21, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has completed the initial expansion of its launch-phase manufacturing capacity. In addition, the company has completed a review of […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces ‘Key Transition’ Focused on Sale, Installation, Qualification of BaroFold Manufacturing System
September 8, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmeceuticals, food and beverage, and other industries, is making an adjustment in its business approach. The company has announced “a key transition in its collaborations with multiple leaders […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Progress Report on UltraShear Nano-CBD Launch, Commercialization Program
August 30, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has released an update regarding launch progress and commercialization program for its revolutionary, best-in-class Nano-CBD product; the product is […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q2 2023 Financial Results, Business Update
August 22, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries, today released financial results for the second quarter ended June 30, 2023, provided a business update, and offered limited guidance for expected achievements through the remainder of […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Hosts Webinar Showcasing Revolutionary UltraShear Platform
August 17, 2023
Pressure BioSciences (OTCQB: PBIO) today announced that its CEO and President Richard T. Schumacher and Director of Marketing and Sales John B. Hollister are the featured speakers at an online webinar scheduled for 11 a.m. ET on Thursday, Aug. 17, 2023. The webinar will showcase an overview of Pressure BioSciences and its core technologies and […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Gratifying ‘Tip of the Iceberg’ Start of Accelerated UltraShear(TM) Nano-CBD Orders
August 9, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries, today announced strongly accelerating orders for its UltraShear(TM)-processed Nano-CBD topical spray product. According to the update, the company has received seven […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Significant Increase in UltraShear-Processed Nanoemulsions
July 26, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food/beverage, and other industries. The company today announced that Canopy CBD Farms LLC (“CCF”), PBIO’s master distributor for cannabis products in North America, has reported a […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Launches Program to Evaluate UltraShear(TM) Technology to Preserve Quality of Fresh Produce
July 25, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide food and beverage, agrochemicals, nutraceuticals and other industries. The company today announced the initiation of studies to evaluate and demonstrate its UltraShear Technology(TM) (“UltraShear(TM)”) platform for producing oil-in-water nanoemulsions […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Phase 2 of Commercialization of Its UltraShear(TM)-Processed Nano-CBD Topical Spray
July 17, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries. The company has announced, in an interview with renowned cannabis business authority Jeffrey Friedland, that PBIO is advancing into phase […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Distribution Agreement with CdC for UltraShear Processed Nano-CBD Topical Spray
July 10, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has announced a partnership with Crème de Canna (“CdC”). According to the announcement, the two companies have entered a […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Key Academic Publication Validates Platform’s Impact in Clean-Label Functional Foods & Beverages
July 6, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, is reporting that its UltraShear(TM) Technology platform delivers transformational capabilities that address leading industry and consumer trends in food […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates for Development and Distribution of UltraShear(TM)-Enhanced Products
July 5, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries. The company today announced its entry into an agreement with Somalab International LLC, a Texas-based leading supplier of novel health […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Webinar, Reports on Positive Results from Third Round of Consumer Testing
June 27, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis, and other industries, has scheduled an online webinar today at 4:30 p.m. ET. The webinar will feature PBIO president and CEO Richard […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Agreement to Provide VST Members with UltraShear Nano-CBD, Other Products
June 13, 2023
Pressure BioSciences (OTCQB: PBIO) has entered a development and supply agreement with the Veterans Service Team (“VST”) to provide world-class, highly effective, and natural wellness products to benefit the mind, body and soul. Set to last five years, the long-term agreement offers VST members exclusive access to custom-designed, hemp-derived, UltraShear-processed nanoemulsions of CBD oil in […]